Literature DB >> 1530921

Hierarchy of responsiveness in vivo and in vitro among T cells expressing distinct Mls-1a-reactive v beta domains.

G A Waanders1, H R McDonald.   

Abstract

In this report we have compared responses of T cells bearing different T cell receptor (TcR) V beta domains, including V beta 6, 7, 8.1 and 9, to the minor lymphocyte stimulatory locus (Mls-1a). The virtually complete deletion of peripheral T cells using these TcR V beta domains in mice expressing Mls-1a verified their Mls-1a reactivity. However, varied responses among these cells following stimulation with Mls-1a in vitro suggested a hierarchy of TcR reactivities for Mls-1a with V beta 6 and V beta 9 greater than V beta 8.1 much greater than V beta 7. This hierarchy was further supported by in vivo studies which showed that V beta 6+CD4+ cells dominated responses to Mls-1a.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530921     DOI: 10.1002/eji.1830220144

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Importance of intrathymic mixed chimerism for the maintenance of skin allograft tolerance across fully allogeneic antigens in mice.

Authors:  M Eto; Y Y Kong; J Uozumi; S Naito; K Nomoto
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

2.  Both H-2- and non-H-2-linked genes influence influenza nucleoprotein epitope recognition by CD4+ T cells.

Authors:  S J Brett; J P Tite
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

3.  Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.

Authors:  S C Hong; G Waterbury; C A Janeway
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 4.  Pathogen-host standoff: immunity to polyomavirus infection and neoplasia.

Authors:  Aron E Lukacher
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  The primary in vivo immune response to Mls-1 (Mtv-7 sag). Route of injection determines the immune response pattern.

Authors:  M Andersson; H Acha-Orbea
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

6.  Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.

Authors:  A E Lukacher; Y Ma; J P Carroll; S R Abromson-Leeman; J C Laning; M E Dorf; T L Benjamin
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

7.  The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.

Authors:  M T Scherer; L Ignatowicz; A Pullen; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

8.  Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.

Authors:  G A Waanders; A N Shakhov; W Held; O Karapetian; H Acha-Orbea; H R MacDonald
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

9.  CD4 expression is differentially required for deletion of MLS-1a-reactive T cells.

Authors:  V A Wallace; A Rahemtulla; E Timms; J Penninger; T W Mak
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.